The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Bio-based Pentylenediamine-Global Market Insights and Sales Trends 2024

Bio-based Pentylenediamine-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1879810

No of Pages : 111

Synopsis
It is an important C5 platform compound. It is a colorless smoky liquid with a smell similar to ammonia. It is easily soluble in water and ethanol.
The global Bio-based Pentylenediamine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Bio-based Pentylenediamine in various end use industries. The expanding demands from the Spinning, Engineering Materials, Medicine and Pesticides, are propelling Bio-based Pentylenediamine market. Purity Above 99.5%, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Purity Above 99.9% segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Bio-based Pentylenediamine market, driven by demand from China, the second largest economy with some signs of stabilising, the Bio-based Pentylenediamine market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bio-based Pentylenediamine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bio-based Pentylenediamine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bio-based Pentylenediamine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bio-based Pentylenediamine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bio-based Pentylenediamine covered in this report include Cathay Biotech Inc., Aphena Pharma Solutions, Bio-Tech Pharmacal, Goodwin Biotechnology, Xenon Pharmaceuticals, Nektar Therapeutics, Midas Pharmaceuticals, Kedrion Biopharma and Xcelthera, etc.
The global Bio-based Pentylenediamine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cathay Biotech Inc.
Aphena Pharma Solutions
Bio-Tech Pharmacal
Goodwin Biotechnology
Xenon Pharmaceuticals
Nektar Therapeutics
Midas Pharmaceuticals
Kedrion Biopharma
Xcelthera
Anichem
ALC Bio Innovations
ACADIA Pharmaceuticals
AbbVie Inc.
Ology Bioservices
QMI - Quality Management
Biomiga
Molecular Targeting Technologies
Global Bio-based Pentylenediamine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bio-based Pentylenediamine market, Segment by Type:
Purity Above 99.5%
Purity Above 99.9%
Global Bio-based Pentylenediamine market, by Application
Spinning
Engineering Materials
Medicine
Pesticides
Organic Synthesis
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Bio-based Pentylenediamine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Bio-based Pentylenediamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Bio-based Pentylenediamine Market Overview
1.1 Bio-based Pentylenediamine Product Overview
1.2 Bio-based Pentylenediamine Market Segment by Type
1.2.1 Purity Above 99.5%
1.2.2 Purity Above 99.9%
1.3 Global Bio-based Pentylenediamine Market Size by Type
1.3.1 Global Bio-based Pentylenediamine Market Size Overview by Type (2018-2029)
1.3.2 Global Bio-based Pentylenediamine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Bio-based Pentylenediamine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Bio-based Pentylenediamine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Bio-based Pentylenediamine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Bio-based Pentylenediamine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Bio-based Pentylenediamine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Bio-based Pentylenediamine Sales Breakdown by Type (2018-2023)
2 Global Bio-based Pentylenediamine Market Competition by Company
2.1 Global Top Players by Bio-based Pentylenediamine Sales (2018-2023)
2.2 Global Top Players by Bio-based Pentylenediamine Revenue (2018-2023)
2.3 Global Top Players by Bio-based Pentylenediamine Price (2018-2023)
2.4 Global Top Manufacturers Bio-based Pentylenediamine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Bio-based Pentylenediamine Market Competitive Situation and Trends
2.5.1 Bio-based Pentylenediamine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Bio-based Pentylenediamine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bio-based Pentylenediamine as of 2022)
2.7 Date of Key Manufacturers Enter into Bio-based Pentylenediamine Market
2.8 Key Manufacturers Bio-based Pentylenediamine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Bio-based Pentylenediamine Status and Outlook by Region
3.1 Global Bio-based Pentylenediamine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Bio-based Pentylenediamine Historic Market Size by Region
3.2.1 Global Bio-based Pentylenediamine Sales in Volume by Region (2018-2023)
3.2.2 Global Bio-based Pentylenediamine Sales in Value by Region (2018-2023)
3.2.3 Global Bio-based Pentylenediamine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Bio-based Pentylenediamine Forecasted Market Size by Region
3.3.1 Global Bio-based Pentylenediamine Sales in Volume by Region (2024-2029)
3.3.2 Global Bio-based Pentylenediamine Sales in Value by Region (2024-2029)
3.3.3 Global Bio-based Pentylenediamine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Bio-based Pentylenediamine by Application
4.1 Bio-based Pentylenediamine Market Segment by Application
4.1.1 Spinning
4.1.2 Engineering Materials
4.1.3 Medicine
4.1.4 Pesticides
4.1.5 Organic Synthesis
4.1.6 Others
4.2 Global Bio-based Pentylenediamine Market Size by Application
4.2.1 Global Bio-based Pentylenediamine Market Size Overview by Application (2018-2029)
4.2.2 Global Bio-based Pentylenediamine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Bio-based Pentylenediamine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Bio-based Pentylenediamine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Bio-based Pentylenediamine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Bio-based Pentylenediamine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Bio-based Pentylenediamine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Bio-based Pentylenediamine Sales Breakdown by Application (2018-2023)
5 North America Bio-based Pentylenediamine by Country
5.1 North America Bio-based Pentylenediamine Historic Market Size by Country
5.1.1 North America Bio-based Pentylenediamine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Bio-based Pentylenediamine Sales in Volume by Country (2018-2023)
5.1.3 North America Bio-based Pentylenediamine Sales in Value by Country (2018-2023)
5.2 North America Bio-based Pentylenediamine Forecasted Market Size by Country
5.2.1 North America Bio-based Pentylenediamine Sales in Volume by Country (2024-2029)
5.2.2 North America Bio-based Pentylenediamine Sales in Value by Country (2024-2029)
6 Europe Bio-based Pentylenediamine by Country
6.1 Europe Bio-based Pentylenediamine Historic Market Size by Country
6.1.1 Europe Bio-based Pentylenediamine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Bio-based Pentylenediamine Sales in Volume by Country (2018-2023)
6.1.3 Europe Bio-based Pentylenediamine Sales in Value by Country (2018-2023)
6.2 Europe Bio-based Pentylenediamine Forecasted Market Size by Country
6.2.1 Europe Bio-based Pentylenediamine Sales in Volume by Country (2024-2029)
6.2.2 Europe Bio-based Pentylenediamine Sales in Value by Country (2024-2029)
7 Asia-Pacific Bio-based Pentylenediamine by Region
7.1 Asia-Pacific Bio-based Pentylenediamine Historic Market Size by Region
7.1.1 Asia-Pacific Bio-based Pentylenediamine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Bio-based Pentylenediamine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Bio-based Pentylenediamine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Bio-based Pentylenediamine Forecasted Market Size by Region
7.2.1 Asia-Pacific Bio-based Pentylenediamine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Bio-based Pentylenediamine Sales in Value by Region (2024-2029)
8 Latin America Bio-based Pentylenediamine by Country
8.1 Latin America Bio-based Pentylenediamine Historic Market Size by Country
8.1.1 Latin America Bio-based Pentylenediamine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Bio-based Pentylenediamine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Bio-based Pentylenediamine Sales in Value by Country (2018-2023)
8.2 Latin America Bio-based Pentylenediamine Forecasted Market Size by Country
8.2.1 Latin America Bio-based Pentylenediamine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Bio-based Pentylenediamine Sales in Value by Country (2024-2029)
9 Middle East and Africa Bio-based Pentylenediamine by Country
9.1 Middle East and Africa Bio-based Pentylenediamine Historic Market Size by Country
9.1.1 Middle East and Africa Bio-based Pentylenediamine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Bio-based Pentylenediamine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Bio-based Pentylenediamine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Bio-based Pentylenediamine Forecasted Market Size by Country
9.2.1 Middle East and Africa Bio-based Pentylenediamine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Bio-based Pentylenediamine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Cathay Biotech Inc.
10.1.1 Cathay Biotech Inc. Company Information
10.1.2 Cathay Biotech Inc. Introduction and Business Overview
10.1.3 Cathay Biotech Inc. Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Cathay Biotech Inc. Bio-based Pentylenediamine Products Offered
10.1.5 Cathay Biotech Inc. Recent Development
10.2 Aphena Pharma Solutions
10.2.1 Aphena Pharma Solutions Company Information
10.2.2 Aphena Pharma Solutions Introduction and Business Overview
10.2.3 Aphena Pharma Solutions Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Aphena Pharma Solutions Bio-based Pentylenediamine Products Offered
10.2.5 Aphena Pharma Solutions Recent Development
10.3 Bio-Tech Pharmacal
10.3.1 Bio-Tech Pharmacal Company Information
10.3.2 Bio-Tech Pharmacal Introduction and Business Overview
10.3.3 Bio-Tech Pharmacal Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Bio-Tech Pharmacal Bio-based Pentylenediamine Products Offered
10.3.5 Bio-Tech Pharmacal Recent Development
10.4 Goodwin Biotechnology
10.4.1 Goodwin Biotechnology Company Information
10.4.2 Goodwin Biotechnology Introduction and Business Overview
10.4.3 Goodwin Biotechnology Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Goodwin Biotechnology Bio-based Pentylenediamine Products Offered
10.4.5 Goodwin Biotechnology Recent Development
10.5 Xenon Pharmaceuticals
10.5.1 Xenon Pharmaceuticals Company Information
10.5.2 Xenon Pharmaceuticals Introduction and Business Overview
10.5.3 Xenon Pharmaceuticals Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Xenon Pharmaceuticals Bio-based Pentylenediamine Products Offered
10.5.5 Xenon Pharmaceuticals Recent Development
10.6 Nektar Therapeutics
10.6.1 Nektar Therapeutics Company Information
10.6.2 Nektar Therapeutics Introduction and Business Overview
10.6.3 Nektar Therapeutics Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Nektar Therapeutics Bio-based Pentylenediamine Products Offered
10.6.5 Nektar Therapeutics Recent Development
10.7 Midas Pharmaceuticals
10.7.1 Midas Pharmaceuticals Company Information
10.7.2 Midas Pharmaceuticals Introduction and Business Overview
10.7.3 Midas Pharmaceuticals Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Midas Pharmaceuticals Bio-based Pentylenediamine Products Offered
10.7.5 Midas Pharmaceuticals Recent Development
10.8 Kedrion Biopharma
10.8.1 Kedrion Biopharma Company Information
10.8.2 Kedrion Biopharma Introduction and Business Overview
10.8.3 Kedrion Biopharma Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Kedrion Biopharma Bio-based Pentylenediamine Products Offered
10.8.5 Kedrion Biopharma Recent Development
10.9 Xcelthera
10.9.1 Xcelthera Company Information
10.9.2 Xcelthera Introduction and Business Overview
10.9.3 Xcelthera Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Xcelthera Bio-based Pentylenediamine Products Offered
10.9.5 Xcelthera Recent Development
10.10 Anichem
10.10.1 Anichem Company Information
10.10.2 Anichem Introduction and Business Overview
10.10.3 Anichem Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Anichem Bio-based Pentylenediamine Products Offered
10.10.5 Anichem Recent Development
10.11 ALC Bio Innovations
10.11.1 ALC Bio Innovations Company Information
10.11.2 ALC Bio Innovations Introduction and Business Overview
10.11.3 ALC Bio Innovations Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.11.4 ALC Bio Innovations Bio-based Pentylenediamine Products Offered
10.11.5 ALC Bio Innovations Recent Development
10.12 ACADIA Pharmaceuticals
10.12.1 ACADIA Pharmaceuticals Company Information
10.12.2 ACADIA Pharmaceuticals Introduction and Business Overview
10.12.3 ACADIA Pharmaceuticals Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.12.4 ACADIA Pharmaceuticals Bio-based Pentylenediamine Products Offered
10.12.5 ACADIA Pharmaceuticals Recent Development
10.13 AbbVie Inc.
10.13.1 AbbVie Inc. Company Information
10.13.2 AbbVie Inc. Introduction and Business Overview
10.13.3 AbbVie Inc. Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.13.4 AbbVie Inc. Bio-based Pentylenediamine Products Offered
10.13.5 AbbVie Inc. Recent Development
10.14 Ology Bioservices
10.14.1 Ology Bioservices Company Information
10.14.2 Ology Bioservices Introduction and Business Overview
10.14.3 Ology Bioservices Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Ology Bioservices Bio-based Pentylenediamine Products Offered
10.14.5 Ology Bioservices Recent Development
10.15 QMI - Quality Management
10.15.1 QMI - Quality Management Company Information
10.15.2 QMI - Quality Management Introduction and Business Overview
10.15.3 QMI - Quality Management Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.15.4 QMI - Quality Management Bio-based Pentylenediamine Products Offered
10.15.5 QMI - Quality Management Recent Development
10.16 Biomiga
10.16.1 Biomiga Company Information
10.16.2 Biomiga Introduction and Business Overview
10.16.3 Biomiga Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Biomiga Bio-based Pentylenediamine Products Offered
10.16.5 Biomiga Recent Development
10.17 Molecular Targeting Technologies
10.17.1 Molecular Targeting Technologies Company Information
10.17.2 Molecular Targeting Technologies Introduction and Business Overview
10.17.3 Molecular Targeting Technologies Bio-based Pentylenediamine Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Molecular Targeting Technologies Bio-based Pentylenediamine Products Offered
10.17.5 Molecular Targeting Technologies Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Bio-based Pentylenediamine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Bio-based Pentylenediamine Industrial Chain Analysis
11.4 Bio-based Pentylenediamine Market Dynamics
11.4.1 Bio-based Pentylenediamine Industry Trends
11.4.2 Bio-based Pentylenediamine Market Drivers
11.4.3 Bio-based Pentylenediamine Market Challenges
11.4.4 Bio-based Pentylenediamine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Bio-based Pentylenediamine Distributors
12.3 Bio-based Pentylenediamine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’